Zobrazeno 1 - 10
of 224
pro vyhledávání: '"N. Burger"'
Autor:
Paras Shah, William R. Taylor, Brianna J. Negaard, Benjamin R. Gochanour, Douglas W. Mahoney, Sara S. Then, Mary E. Devens, Patrick H. Foote, Karen A. Doering, Kelli N. Burger, Brandon Nikolai, Michael W. Kaiser, Hatim T. Allawi, John C. Cheville, John B. Kisiel, Matthew T. Gettman
Publikováno v:
Life, Vol 14, Iss 8, p 1024 (2024)
Introduction: Non-invasive assays are needed to better discriminate patients with prostate cancer (PCa) to avoid over-treatment of indolent disease. We analyzed 14 methylated DNA markers (MDMs) from urine samples of patients with biopsy-proven PCa re
Externí odkaz:
https://doaj.org/article/6ad792f6a8a5470c9e125e29b0e26bc6
Autor:
Emmalee J Northrop-Albrecht, Chung Wah Wu, Calise K Berger, William R Taylor, Patrick H Foote, Karen A Doering, Anna M Gonser, Aditya Bhagwate, Zhifu Sun, Douglas W Mahoney, Kelli N Burger, Lisa A Boardman, John B Kisiel
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0308711 (2024)
Regular screening for colorectal cancer (CRC) is critical for early detection and long-term survival. Despite the current screening options available and advancements in therapies there will be around 53,000 CRC related deaths this year. There is gre
Externí odkaz:
https://doaj.org/article/6d7a94ddfe824517a2e217f4cc9f03f0
Autor:
Derek W. Ebner, Kelli N. Burger, Brendan Broderick, Douglas W. Mahoney, Todd A. Kellogg, Andres Acosta, John B. Kisiel
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 7, Pp 902-910 (2023)
Background and Aims: Bariatric and metabolic surgery (BMS) may adversely affect noninvasive stool tests for colorectal cancer (CRC) screening through several mechanisms. Multitarget stool DNA (mt-sDNA) is approved for CRC screening; however, performa
Externí odkaz:
https://doaj.org/article/5017845365d64e6dbf5d01d23d1d701d
Autor:
Shounak Majumder, Thorvardur R. Halfdanarson, Calise K. Berger, Patrick H. Foote, Xiaoming Cao, Maria C. McGlinch, Brianna J. Gysbers, Jaime de La Fuente, Mariah J. Robran, Karen A. Doering, Kelli N. Burger, William E. Bamlet, Ann L. Oberg, Douglas W. Mahoney, Rondell P. Graham, William R. Taylor, Gloria M. Petersen, John B. Kisiel
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 3, Pp 409-416 (2022)
Background and Aims: Methylated DNA markers (MDMs) accurately identify several different cancer types, but there are limited data for pancreatic neuroendocrine tumors (pNETs). We aimed to identify MDM candidates in tissue that differentiate pNETs fro
Externí odkaz:
https://doaj.org/article/90339e48a18143f3be865fc2ccd81cc1
Autor:
Derek W. Ebner, Jason D. Eckmann, Kelli N. Burger, Douglas W. Mahoney, Thomas J. Whitaker, Ivy A. Petersen, John B. Kisiel
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 5, Pp 746-754 (2022)
Background and Aims: Multitarget stool DNA (mt-sDNA) is approved for average-risk colorectal cancer screening; test performance in persons with prior radiation therapy (RT) has not been studied. RT can induce gastrointestinal bleeding and alter DNA m
Externí odkaz:
https://doaj.org/article/bcf2291e38ed4f89830a58e69d17e50d
Autor:
Jamie N. Bakkum-Gamez, Mark E. Sherman, Seth W. Slettedahl, Douglas W. Mahoney, Maureen A. Lemens, Shannon K. Laughlin-Tommaso, Matthew R. Hopkins, Ann VanOosten, Viji Shridhar, Julie K. Staub, Xiaoming Cao, Patrick H. Foote, Megan A. Clarke, Kelli N. Burger, Calise K. Berger, Maria C. O'Connell, Karen A. Doering, Karl C. Podratz, Christopher C. DeStephano, J. Kenneth Schoolmeester, Sarah E. Kerr, Nicolas Wentzensen, William R. Taylor, John B. Kisiel
Publikováno v:
Gynecologic Oncology. 174:11-20
Autor:
Karthik V. Giridhar, Fergus J. Couch, Jason P. Sinnwell, Seth W. Slettedahl, William R. Taylor, Douglas W. Mahoney, Patrick H. Foote, Maria C. O’Connell, Mariah J. Robran, Mary E. Devens, Anna M. Gonser, Nicole Larson, Karen A. Doering, Kelli N. Burger, Michael Kaiser, Hatim Allawi, Kathryn Ruddy, Janet Olson, John B. Kisiel
Publikováno v:
Cancer Research. 83:P2-11
Objective: Aberrantly methylated DNA may be used to detect minimal residual disease or early recurrence in breast cancer. As a 1st step, we aimed to develop an MDM panel to delineate between healthy women, stage I-III breast cancer in remission with
Autor:
John B. Kisiel, David A. Ahlquist, Suresh T. Chari, Gloria M. Petersen, Hatim T. Allawi, Graham P. Lidgard, Karen A. Doering, Jaime de la Fuente, Neil Postier, Kelli N. Burger, William R. Bamlet, Douglas W. Mahoney, Chung Wah Wu, Calise K. Berger, Patrick H. Foote, William R. Taylor, Shounak Majumder
Supplemental Figure 3 shows the distributions in plasma from controls and PDAC patients by stage of disease and standardized copy numbers of all MDMs other than HOXA1 and PRKCB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a717d799158338ead95fc1b4cf073db
https://doi.org/10.1158/1078-0432.22483674
https://doi.org/10.1158/1078-0432.22483674
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Table 1 Baseline characteristics of patients in Primary and Metastatic Tissue MDM Concordance Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6140eadd916a8d5b2bed2b2dd65a56
https://doi.org/10.1158/1078-0432.22478361.v1
https://doi.org/10.1158/1078-0432.22478361.v1
Autor:
John B. Kisiel, David A. Ahlquist, Suresh T. Chari, Gloria M. Petersen, Hatim T. Allawi, Graham P. Lidgard, Karen A. Doering, Jaime de la Fuente, Neil Postier, Kelli N. Burger, William R. Bamlet, Douglas W. Mahoney, Chung Wah Wu, Calise K. Berger, Patrick H. Foote, William R. Taylor, Shounak Majumder
Supplementary Tables and Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2910971755fc70ffb556e609909e8e
https://doi.org/10.1158/1078-0432.22483671
https://doi.org/10.1158/1078-0432.22483671